“…Therefore, overexpression of miR-155 suggests a risk factor for breast cancer 10 . Currently, methods for detection of miRNA mainly include reverse transcription polymerase chain reaction (RT-PCR) 11 – 13 , northern blotting 14 , 15 , microarray technique 16 , 17 , in situ hybridization 18 – 20 and so on. Despite the advantages, these methods still suffer some disadvantages such as requiring expensive instruments and reagents, miRNA labeling, large amounts of miRNA and relatively pure miRNA samples 21 .…”